Synthace Stock

Life Sciences R&D cloud platform

Sign up today and learn more about Synthace Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Synthace Stock

Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.

Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.

Funding History

August 2013$1.5M
January 2015$2.9M
September 2017$10.5M
June 2018$3.1M
December 2018$25.4M
November 2021$6.8M
November 2021$26.8M

Management

CEO

Guy Levy-Yurista

Co-founder & Chief Scientific Officer

Markus Gershater

Chief Product Officer

Mathieu Ayel

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo